title: Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy.
authors.affiliation: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: N
authors.initials: N
authors.lastname: Singh
authors.affiliation: Department of Ophthalmology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: R
authors.initials: R
authors.lastname: Bansal
authors.affiliation: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: D
authors.initials: D
authors.lastname: Behera
authors.affiliation: Department of Ophthalmology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy*; D002830:Choroid Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology*; D008297:Male
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab